Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-25-057622
Filing Date
2025-06-09
Accepted
2025-06-09 08:10:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2517439d2_sc14d9c.htm SC14D9C 6979
  Complete submission text file 0001104659-25-057622.txt   8874
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filed by) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-92657 | Film No.: 251032876
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)